08-JAN-2026 6:11

SWOG CURRENT AND PROJECTED ACCRUAL

THERAPEUTIC STUDIES -- ACCRUAL REGISTRATIONS ONLY

COMMITTEE Accrual
Last
12 Months
Accrual
Last
7 Days
Yearly
Projection
(7 Days)
Accrual
Last
30 Days
Yearly
Projection
(30 Days)
Accrual
Last
60 Days
Yearly
Projection
(60 Days)
BREAST 1010 13 678 78 950 168 1023
ERLYTX 87 1 52 4 49 8 49
GI 190 3 157 10 122 24 146
GU 436 5 261 21 256 54 329
LEUK 137 1 52 10 122 21 128
LUNG 171 1 52 17 207 33 201
LYMPH 400 7 365 24 292 58 353
MELAN 276 0 0 1 12 2 12
MMYEL 139 2 104 8 97 11 67
MULT 23 1 52 4 49 9 55
OTHER 40 1 52 3 37 9 55
PREV 2 0 0 0 0 0 0
SXQOL 2 0 0 0 0 0 0
Total 2913 35 1825 180 2193 397 2418

08-JAN-2026 6:11

SWOG CURRENT AND PROJECTED ACCRUAL

NON-THERAPEUTIC STUDIES -- ACCRUAL REGISTRATIONS ONLY

COMMITTEE Accrual
Last
12 Months
Accrual
Last
7 Days
Yearly
Projection
(7 Days)
Accrual
Last
30 Days
Yearly
Projection
(30 Days)
Accrual
Last
60 Days
Yearly
Projection
(60 Days)
CCD 116 2 104 13 158 25 152
ERLYTX 10 0 0 0 0 0 0
LEUK 661 8 417 43 524 87 530
LUNG 316 5 261 27 329 55 335
OTHER 36 0 0 3 37 5 30
PEOLC 130 1 52 9 110 27 164
PREV 209 5 261 23 280 40 244
SURV 18 0 0 0 0 4 24
SXQOL 556 10 522 39 475 85 517
Total 2052 31 1617 157 1913 328 1996

08-JAN-2026 6:11

SWOG CURRENT AND PROJECTED ACCRUAL

ACCRUAL REGISTRATIONS ONLY

COMMITTEE Accrual
Last
12 Months
Accrual
Last
7 Days
Yearly
Projection
(7 Days)
Accrual
Last
30 Days
Yearly
Projection
(30 Days)
Accrual
Last
60 Days
Yearly
Projection
(60 Days)
BREAST 1010 13 678 78 950 168 1023
CCD 116 2 104 13 158 25 152
ERLYTX 97 1 52 4 49 8 49
GI 190 3 157 10 122 24 146
GU 436 5 261 21 256 54 329
LEUK 798 9 470 53 645 108 657
LUNG 487 6 313 44 536 88 536
LYMPH 400 7 365 24 292 58 353
MELAN 276 0 0 1 12 2 12
MMYEL 139 2 104 8 97 11 67
MULT 23 1 52 4 49 9 55
OTHER 76 1 52 6 73 14 85
PEOLC 130 1 52 9 110 27 164
PREV 211 5 261 23 280 40 244
SURV 18 0 0 0 0 4 24
SXQOL 558 10 522 39 475 85 517
Total 4965 66 3443 337 4104 725 4413

08-JAN-2026 6:11

SWOG CURRENT AND PROJECTED ACCRUAL

THERAPEUTIC STUDIES - ACCRUAL REGISTRATIONS BY SWOG INSTITUTIONS ONLY

COMMITTEE Accrual
Last
12 Months
Accrual
Last
7 Days
Yearly
Projection
(7 Days)
Accrual
Last
30 Days
Yearly
Projection
(30 Days)
Accrual
Last
60 Days
Yearly
Projection
(60 Days)
BREAST 631 8 417 49 597 104 633
ERLYTX 46 0 0 2 24 5 30
GI 135 2 104 6 73 17 103
GU 367 5 261 20 244 44 268
LEUK 82 0 0 7 85 14 85
LUNG 107 0 0 10 122 16 97
LYMPH 258 5 261 17 207 43 262
MELAN 174 0 0 1 12 2 12
MMYEL 88 1 52 5 61 7 43
MULT 8 0 0 1 12 2 12
OTHER 40 1 52 3 37 9 55
PREV 2 0 0 0 0 0 0
SXQOL 2 0 0 0 0 0 0
Total 1940 22 1147 121 1474 263 1600

08-JAN-2026 6:11

SWOG CURRENT AND PROJECTED ACCRUAL

NON-THERAPEUTIC STUDIES - ACCRUAL REGISTRATIONS BY SWOG INSTITUTIONS ONLY

COMMITTEE Accrual
Last
12 Months
Accrual
Last
7 Days
Yearly
Projection
(7 Days)
Accrual
Last
30 Days
Yearly
Projection
(30 Days)
Accrual
Last
60 Days
Yearly
Projection
(60 Days)
CCD 102 1 52 10 122 21 128
ERLYTX 10 0 0 0 0 0 0
LEUK 293 5 261 17 207 41 250
LUNG 198 2 104 18 219 35 213
OTHER 36 0 0 3 37 5 30
PEOLC 92 1 52 7 85 21 128
PREV 207 3 157 21 256 38 231
SURV 18 0 0 0 0 4 24
SXQOL 373 9 470 27 329 56 341
Total 1329 21 1096 103 1255 221 1345

08-JAN-2026 6:11

SWOG CURRENT AND PROJECTED ACCRUAL

ACCRUAL REGISTRATIONS BY SWOG INSTITUTIONS ONLY

COMMITTEE Accrual
Last
12 Months
Accrual
Last
7 Days
Yearly
Projection
(7 Days)
Accrual
Last
30 Days
Yearly
Projection
(30 Days)
Accrual
Last
60 Days
Yearly
Projection
(60 Days)
BREAST 809 10 522 64 779 128 779
CCD 134 1 52 8 97 20 122
ERLYTX 56 0 0 2 24 5 30
GI 137 1 52 6 73 16 97
GU 384 5 261 21 256 47 286
LEUK 375 5 261 24 292 55 335
LUNG 309 3 157 31 377 54 329
LYMPH 258 5 261 17 207 43 262
MELAN 174 0 0 1 12 2 12
MMYEL 82 1 52 5 61 7 43
MULT 24 0 0 3 37 6 37
OTHER 258 2 104 16 195 32 195
PEOLC 96 1 52 6 73 19 116
PREV 209 3 157 21 256 38 231
SURV 18 0 0 0 0 4 24
SXQOL 375 9 470 27 329 56 341
Total 3698 46 2401 252 3068 532 3239

08-JAN-2026 6:11

SWOG CURRENT AND PROJECTED ACCRUAL

THERAPEUTIC STUDIES COORDINATED BY SWOG

ACCRUAL REGISTRATIONS ONLY

COMMITTEE Accrual
Last
12 Months
Accrual
Last
7 Days
Yearly
Projection
(7 Days)
Accrual
Last
30 Days
Yearly
Projection
(30 Days)
Accrual
Last
60 Days
Yearly
Projection
(60 Days)
BREAST 851 13 678 61 743 133 810
ERLYTX 83 1 52 4 49 8 49
GI 109 1 52 5 61 13 79
GU 258 3 157 18 219 40 244
LEUK 106 1 52 5 61 14 85
LUNG 137 1 52 14 170 27 164
LYMPH 325 6 313 21 256 46 280
MMYEL 127 1 52 7 85 10 61
MULT 23 1 52 4 49 9 55
Total 2019 28 1460 139 1693 300 1827

08-JAN-2026 6:11

SWOG CURRENT AND PROJECTED ACCRUAL

ACCRUAL REGISTRATIONS ONLY

Inst. Accrual
Last
12 Months
Accrual
Last
7 Days
Yearly
Projection
(7 Days)
Accrual
Last
30 Days
Yearly
Projection
(30 Days)
Accrual
Last
60 Days
Yearly
Projection
(60 Days)
Member 1915 24 1252 128 1558 294 1790
AFFIL 128 2 104 18 219 30 183
CCOP/NCORP 1226 17 887 78 950 160 974
Non-SWOG 1692 19 991 109 1327 237 1443
Total 4961 62 3234 333 4054 721 4390

08-JAN-2026 6:11

STUDIES OPENED THIS MONTH

ADMIN STUDYID STNAME REGTYPE Opened? Open Date
GI S2433 PANC, KRAS WT, Met, SOC Chemo +/- Panitumumab 1 Y 26-DEC-25

08-JAN-2026 6:11

STUDIES CLOSED THIS MONTH

ADMIN STUDYID STNAME REGTYPE Opened? Open Date
GU A031801 GU, mRCC, Cabozantinib ± Radium-223 1 E 19-DEC-25
ERLYTX EAY191-S3 ComboMATCH: Adv Solid Tumors, Pac+Ipatasertib 1 T 18-DEC-25
LUNG S1827 SCLC, MRI Surveillance +/- PCI 1 N 15-DEC-25
OTHER EA3161 HNC, HPV+ OPCA, (cisplatin+RT) +/- Nivo 1 E 07-JAN-26
OTHER EA3161 HNC, HPV+ OPCA, (cisplatin+RT) +/- Nivo 2 E 07-JAN-26
GI A021806 Pancreas, Perioperative vs Adjuvant Chemo 0 E 05-JAN-26
GI A021806 Pancreas, Perioperative vs Adjuvant Chemo 1 E 05-JAN-26

08-JAN-2026 6:11

STUDIES WITH 3 OR MORE REGISTRATIONS THIS WEEK

ADMIN STUDYID STNAME REGTYPE Registrations
BREAST S2212 Breast, TNBC, Neoadj Chemo + Pembro 1 11
LUNG LUNGMAP NSCLC, Adv, Master 2 9
LEUK MYELOMATCH MSRP for the NCI myeloMATCH Clinical Trials 1 8
LUNG LUNGMAP NSCLC, Adv, Master 1 5
SXQOL S2013 I-CHECKIT: ICI toxicity risk prediction study 1 5
SXQOL S2205 ICE COMPRESS: Reduction of CIPN from Taxanes 1 5
BREAST S2206 Brst, Stg II-III, MP2, Neoadj Chemo +/- Durva 1 4
LYMPH S2308 FL, LTB, Mosunetuzumab vs Rituximab 1 4
PREV NRGCC005 Colon,Non-AdvancedAdenomas,Colonoscopy5v10yrs 1 3